Literature DB >> 12714541

Sociodemographic indicators and risk of brain tumours.

Peter D Inskip1, Robert E Tarone, Elizabeth E Hatch, Timothy C Wilcosky, Howard A Fine, Peter M Black, Jay S Loeffler, William R Shapiro, Robert G Selker, Martha S Linet.   

Abstract

BACKGROUND: To better understand patterns of occurrence or diagnosis of brain tumours in different segments of the population, we evaluated associations between sociodemographic variables and the relative incidence of brain tumours as part of a multi-faceted case-control study.
METHODS: The study was conducted at hospitals in three US cities between 1994 and 1998. In all, 489 glioma cases (354 high-grade, 135 low-grade), 197 meningioma cases, 96 acoustic neuroma cases, and 799 controls admitted to the same hospitals for any of a variety of non-neoplastic diseases or conditions were enrolled and interviewed. Logistic regression was used to estimate odds ratios (OR), calculate 95% CI, and test for trends.
RESULTS: The OR showed significant positive associations with household income for low-grade glioma, meningioma, and acoustic neuroma, but not for high-grade glioma. Positive associations were observed with level of education for low-grade glioma and acoustic neuroma, but not for high-grade glioma or meningioma. Jewish religion was associated with a significantly elevated risk for meningioma (OR = 4.3; 95% CI: 2.0-9.0). Being single at the time of tumour diagnosis or enrolment was associated with significantly reduced risks for meningioma (OR = 0.4; 95% CI: 0.3-0.6) and low- or high-grade glioma (OR = 0.6; 95% CI: 0.5-0.8), but not for acoustic neuroma.
CONCLUSIONS: Associations with sociodemographic variables varied considerably among the different subtypes of brain tumour, including between low-grade and high-grade glioma. The general pattern was for associations with indicators of affluence and education to be stronger for tumours that tend to grow more slowly and have less catastrophic effects, although the evidence was mixed for meningioma. We cannot isolate the specific factors underlying the observed associations, but intrapopulation differences in the completeness or timing of diagnosis may have played a role. There is less opportunity for such influences to operate for the rapidly progressing, high-grade gliomas than for more slowly growing tumours.

Entities:  

Mesh:

Year:  2003        PMID: 12714541     DOI: 10.1093/ije/dyg051

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  20 in total

1.  Initial care and outcome of glioblastoma multiforme patients in 2 diverse health care scenarios in Brazil: does public versus private health care matter?.

Authors:  Luiz Victor Maia Loureiro; Lucíola de Barros Pontes; Donato Callegaro-Filho; Ludmila de Oliveira Koch; Eduardo Weltman; Elivane da Silva Victor; Adrialdo José Santos; Lia Raquel Rodrigues Borges; Roberto Araújo Segreto; Suzana Maria Fleury Malheiros
Journal:  Neuro Oncol       Date:  2014-07       Impact factor: 12.300

2.  Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.

Authors:  Justin T Jordan; Amy E Sanders; Terri Armstrong; Tony Asher; Amy Bennett; Erin Dunbar; Nimish Mohile; P Leia Nghiemphu; Timothy R Smith; Douglas E Ney
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

3.  The effect of socioeconomic status on gross total resection, radiation therapy and overall survival in patients with gliomas.

Authors:  Sayantan Deb; Arjun Vivek Pendharkar; Matthew K Schoen; Sean Altekruse; John Ratliff; Atman Desai
Journal:  J Neurooncol       Date:  2017-03-03       Impact factor: 4.130

4.  Meningioma and schwannoma risk in adults in relation to family history of cancer.

Authors:  Deirdre A Hill; Martha S Linet; Peter M Black; Howard A Fine; Robert G Selker; William R Shapiro; Peter D Inskip
Journal:  Neuro Oncol       Date:  2004-10       Impact factor: 12.300

5.  Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system.

Authors:  Deborah Boyett; Connor J Kinslow; Samuel S Bruce; Adam M Sonabend; Ali I Rae; Guy M McKhann; Michael B Sisti; Jeffrey N Bruce; Simon K Cheng; Tony J C Wang
Journal:  J Neurooncol       Date:  2019-05-03       Impact factor: 4.130

6.  Socio-economic characteristics of patients with glioblastoma multiforme.

Authors:  Samiul Muquit; Ruth Parks; Surajit Basu
Journal:  J Neurooncol       Date:  2015-09-03       Impact factor: 4.130

Review 7.  Racial, ethnic and socioeconomic disparities in the treatment of brain tumors.

Authors:  William T Curry; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

8.  Racial Differences in Disease Presentation and Management of Intracranial Meningioma.

Authors:  C Lane Anzalone; Amy E Glasgow; Jamie J Van Gompel; Matthew L Carlson
Journal:  J Neurol Surg B Skull Base       Date:  2018-12-21

9.  Incidence of first primary central nervous system tumors in California, 2001-2005.

Authors:  Monica Brown; Rudolph Schrot; Katrina Bauer; Deanna Letendre
Journal:  J Neurooncol       Date:  2009-04-02       Impact factor: 4.130

10.  Radiation-induced optic neuritis after pituitary adenoma radiosurgery in a patient with multiple sclerosis: case report.

Authors:  Thomas B Daniels; Bruce E Pollock; Robert C Miller; Claudia F Lucchinetti; Jacqueline A Leavitt; Paul D Brown
Journal:  J Neurooncol       Date:  2008-12-20       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.